Shanghai Meiji Health Science and Technology Co., Ltd. Report issue

Government

Organization Overview

First Clinical Trial
2009
NCT04651023
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai Meiji Health Science and Technology Co., Ltd.

Active Ingredients

Drugs in Other Trials (2)

amino acids (Freamine) (1 trial)

nelumbo nucifera leaf extract (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2